Event-Driven Stocks

Vyome Holdings, Inc

HINDNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs2 good4 warning2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$319,714$8.0M$8.7M$11.2M$13.6M$11.3M
Operating income−$10.5M−$7.7M−$15.4M−$46.4M−$5.9M−$12.5M
Net income−$10.3M−$7.1M−$11.4M−$46.2M−$8.8M−$21.6M
Total assets$6.5M$4.8M$10.7M$11.1M$120.0M$37.1M
Total liabilities$2.7M$5.0M$4.0M$7.5M$8.2M$22.6M
Equity$3.8M−$253,000$6.7M$3.7M$44.3M$14.5M
EPS (diluted)$-4.86$-13.83$-110.87$-108.90$-61.88$-5.54
Shares out.11.3M23.5M2.6M18.6M10.0M7.7M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−3269.4%
Net margin
−3209.7%
Return on equity
−272.8%
Return on assets
−157.9%
Return on capital (ROCE)
−277.8%
Liabilities / assets
42.1%
Debt / equity
0.73×
Book value / share
$0.33
Revenue growth (YoY)
−96.0%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-50.57distress
Accruals / assets
100.2%clean
Beneish M-Score
-18.49normal
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
42
/ 100
Profitability 0Growth 0Catalyst 67Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

2 severe4 warning2 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026123,1322.6+1.4%
Apr 30, 2026121,4835.2-15.6%
Apr 15, 2026143,9018.8-9.2%
Mar 31, 2026158,4744.9+23.3%
Mar 13, 2026128,5132.5-38.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)